RESTYLANE® EYELIGHT™

RESTYLANE® EYELIGHT™ Product Description
RESTYLANE® EYELIGHT™ is an injectable hyaluronic acid-based gel designed to address infraorbital hollows. It is created using crosslinked HA from Streptococcus species bacteria and is suspended in phosphate-buffered saline. The product has a HA concentration of 20 mg/mL.

Transparent, viscous, and sterile gel
Packaged with safety and efficacy for use in targeted infraorbital hollowing

RESTYLANE® EYELIGHT™ Key Features and Benefits
This product offers effective correction for volume loss, particularly in the infraorbital area, ensuring patient satisfaction with minimal downtime.

Hydration improvement: Restores volume while maintaining a natural hydration level
Long-lasting results: A single treatment can last up to 12 months
Natural-looking corrections: Smooth gel ensures even integration

RESTYLANE® EYELIGHT™ Composition
The filler is primarily composed of:

Hyaluronic acid: Concentration of 20 mg/mL, crosslinked with BDDE
Phosphate-buffered saline (pH 7) for compatibility

RESTYLANE® EYELIGHT™ Intended Purpose / Indications
The filler is designed for improving the appearance of infraorbital hollowing in patients over 21 years of age.

Specific areas: Lower eyelids and adjacent midface regions
Ideal for volume restoration and correction of mild to moderate hollowing

RESTYLANE® EYELIGHT™ Injection and Treatment Areas
It is primarily injected into the supraperiosteal plane in the infraorbital region.

Injection areas: Infraorbital hollows
Techniques: Linear threading, retrograde/antegrade, and micro-bolus

RESTYLANE® EYELIGHT™ Reconstitution and Preparation Guidelines
This product comes ready-to-use and does not require reconstitution.

Ensure aseptic handling during preparation and injection
Use provided 29 G x ½” needle or compatible cannulas

RESTYLANE® EYELIGHT™ Administration and Dosage
A trained healthcare professional should administer the treatment. The maximum recommended dosage is 1 mL per side per session.

Administer slowly to avoid intravascular injection
Additional sessions may be scheduled if more than 1 mL is required per side

RESTYLANE® EYELIGHT™ Storage Instructions
Store the product at up to 25°C (77°F). Avoid freezing and prolonged exposure to sunlight.

Shelf life: As indicated on the package
Keep the product in original packaging until use

RESTYLANE® EYELIGHT™ Contraindications
The product is contraindicated in patients with:

Severe allergies or history of anaphylaxis
Active skin infections in the treatment area
Sensitivity to hyaluronic acid or amide anesthetics

RESTYLANE® EYELIGHT™ Precautions and Warnings
Patients with a history of bleeding disorders or those taking anticoagulants may experience increased bruising. Avoid use during pregnancy or lactation.

Do not inject into vascular-rich areas
Take care to avoid intravascular injections, which may cause complications like ischemia or necrosis

RESTYLANE® EYELIGHT™ Post-Treatment Care
Patients are advised to minimize exposure to sun, heat, and strenuous activities following treatment.

Apply ice packs if swelling occurs
Avoid makeup for at least 24 hours

RESTYLANE® EYELIGHT™ Side Effects and Adverse Reactions
Common side effects include redness, bruising, swelling, and tenderness at the injection site. These are generally mild and resolve within 7 days.

Rare but severe reactions: Vascular occlusion and granuloma formation
Instructions for managing side effects: Massage, cold compress, or enzyme-based correction

RESTYLANE® EYELIGHT™ Patient Eligibility
This product is approved for adults aged 21 and older with mild to moderate infraorbital hollowing.

Not suitable for patients with autoimmune conditions or hypersensitivity to HA
A thorough medical history should be taken before treatment

RESTYLANE® EYELIGHT™ Follow-Up and Maintenance
Patients may require follow-up sessions every 6 to 12 months to maintain results.

Periodic touch-ups ensure consistent appearance
Assess patient satisfaction and desired corrections during follow-ups

RESTYLANE® EYELIGHT™ Manufacturer and Regulatory Information
The product is manufactured by Q-Med AB in Sweden and distributed by Galderma Laboratories, L.P. It complies with all relevant medical device regulations, including CE marking.

Contact information: 1-855-425-8722
FDA-approved for use in the U.S.

RESTYLANE® EYELIGHT™ FAQ
Q: What makes RESTYLANE® EYELIGHT™ unique?
A: It is specifically formulated for infraorbital hollowing, offering natural results with minimal downtime.
Q: How long does the treatment last?
A: Results typically last up to 12 months, depending on the patient and treatment technique.
Q: Is it safe for all skin types?
A: Yes, though individuals with dark skin types may have a higher risk of hyperpigmentation or scarring.